Achieve Life Sciences (ACHV) Assets Average (2011 - 2026)

Achieve Life Sciences has disclosed Assets Average across 16 years of filings, most recently posting $37.4 million for Q1 2026.

• Quarterly Assets Average rose 13.49% year-over-year to $37.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.4 million (up 13.49% YoY) and the FY2025 annual result came in at $40.2 million, up 38.65% from the prior year.
• Assets Average slipped to $37.4 million in Q1 2026, from $46.9 million in the prior quarter.
• Over five years, Assets Average peaked at $67.4 million in Q2 2024 and troughed at $21.9 million in Q4 2023.
• A 5-year average of $39.0 million and a median of $37.4 million in 2026 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average sank 42.39% — and 2024, when it soared 171.2%.
• Tracing ACHV's Assets Average over 5 years: stood at $26.8 million in 2022, then fell by 18.6% to $21.9 million in 2023, then surged by 98.02% to $43.3 million in 2024, then rose by 8.41% to $46.9 million in 2025, then declined by 20.18% to $37.4 million in 2026.
• Business Quant data shows ACHV's Assets Average at $37.4 million in Q1 2026, $46.9 million in Q4 2025, and $55.5 million in Q3 2025.